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otential Bioeffects
f Ultrasonic Destruction
f Microbubble Contrast Agents*
alph V. Shohet, MD,†
aul A. Grayburn, MD, FACC‡
allas, Texas
t is well known that microbubble destruction can occur
uring contrast echocardiography, primarily by acoustic
avitation (1). The propensity of microbubbles to undergo
his process when exposed to ultrasound depends on phys-
cal properties of both the bubbles themselves and the
ltrasound beam. Higher rarefactional peak amplitude (a
easure of ultrasonic acoustic power) and lower frequencies
ause greater microbubble destruction (1–3). Thickness,
ompressibility, and elasticity of the microbubble shell are
mportant factors in their susceptibility to ultrasound-
ediated destruction (4). The ability to destroy micro-
ubbles has useful clinical applications, allowing the quan-
ification of myocardial perfusion using replenishment
urves (5). Also, we and others (6) have begun to investigate
his attribute of microbubbles as a method for targeting
ene or drug delivery.
See page 1464
It also has been suggested that the destruction of micro-
ubbles may have adverse effects, such as induction of
entricular ectopy (7), increased vascular permeability (8,9),
nd even cell death within the exposed organ or tissue (10).
n this issue of the Journal, Miller et al. (11) advance our
nowledge of this important area by carefully examining the
ffects of destruction of a commercially available contrast
gent (Definity, Bristol Myers-Squibb, Billerica, Massachu-
etts) using a clinical ultrasound machine (Vingmed System
, General Electric, Cincinnati, Ohio) and standard ultra-
onic acoustic power settings in a dog model. This choice of
odel is relevant because most previous studies of the
ioeffects of microbubble destruction have been performed
sing rodents (8–10,12–14) or isolated, perfused rabbit
earts (15).
Miller et al. (11) found leakage of Evans Blue dye, an
ccepted marker of vascular permeability, along the short-
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Division of Cardiology, Department of Internal Medicine, University of
exas Southwestern Medical Center and the ‡Baylor University Medical Center,
allas, Texas. Dr. Grayburn has received grants from Bristol-Myers Squibb, Philipsp
ltrasound, and EVALVE Inc. He also is a consultant for POINT Biomedical
manufacturer of microbubbles).xis scan plane of the left ventricle. This increased vascular
ermeability was present mainly in a transmural pattern
cross the anterior wall, which is not surprising, because the
osterior wall is likely to be protected by attenuation of the
ltrasound beam by the intervening bubbles in the ventric-
lar chamber. Moreover, the Evans blue dye content was
reatest for the highest acoustic power (2.2 MPA vs.1.2
PA) setting in open chest dogs. There was, nonetheless,
ome evidence of increased vascular permeability in closed
hest dogs as well, with no evidence of Evans blue dye
xtravasation in sham-treated dogs. Although this evidence
emonstrates that microbubble destruction, using the con-
rast agent and ultrasound settings used in this study, causes
ncreased vascular permeability, it is not clear how long this
ffect lasts. It is possible that this vascular permeability is
ompletely reversible. Moreover, transient increased vascu-
ar permeability may be an important factor in gene or drug
elivery by ultrasound-targeted microbubble destruction.
urther studies are needed to assess the physiological results
nd persistence of this phenomenon.
Of greater concern is the finding that increased pro-
idium iodide staining was present in all six open-chest
ogs that received bubbles and cardiac ultrasound. This
tain is moderately specific for cell death because propidium
s excluded from living cells. Although the histologic meth-
ds used did not allow distinction between endothelial cells,
ardiomyocytes, or fibroblasts, it is clear that substantially
ore propidium iodide-stained cells were present within the
can plane (27.5  16.5/mm2 vs. 2.3  2.0/mm2). A
revious study showing a mild troponin leak in closed-chest
ats after ultrasonic microbubble destruction suggests that at
east some of these cells were cardiomyocytes (12). Unfor-
unately, the present study did not measure propidium
odide staining in the closed chest model, nor did it measure
iomarkers specific for cardiomyocyte injury. Thus, we do
ot know whether similar damage would occur in the more
linically pertinent situation of the closed chest model. A
revious small study in human subjects did not find evidence
f myocardial injury as evidenced by myocardial enzymes,
uch as creatine kinase-MB or troponin I (16).
Finally, the authors showed no evidence of ventricular
ctopy in sham treatment or the lower power setting (1.2
PA) but a substantial increase in premature ventricular
ontractions with higher acoustic power (2.2 MPA) in the
pen chest model. It is probable that the ventricular ectopy
s related to the relatively high power delivered directly to
he exposed heart; ventricular ectopy was observed primarily
n the open-chest dogs in the present study. It also is
ossible that ectopy was related to the specific microbubble
sed in this study. A recent large clinical trial using a
on-perfluorocarbon gas microbubble showed no evidence
f ventricular ectopy in humans (17). An additional expla-
ation for this discordance, suggested by the authors, is that
rolonged microbubble destruction (10 min) within the
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Editorial Comment April 4, 2006:1469–70ame scan plane is unlikely in human studies of myocardial
erfusion, wherein the scan plane is frequently changed to
valuate multiple myocardial regions.
The investigation of bioeffects of microbubble destruction
s a complex area of investigation because of a large number
f involved variables. Some of the important ultrasound
ariables are acoustic power, frequency, duration, beam
rofile, and attenuation. Microbubble variables include shell
omposition, encapsulated gas, dose, concentration, and
uration of infusion. Patient variables have not been studied
ut should include body habitus (which affects attenuation),
ardiac output or transmyocardial flow (which might affect
icrobubble dose and concentration), and perhaps under-
ying diseases. It seems likely that electrolyte concentrations
nd ischemia, as examples, might influence vulnerability to
otential toxic effects of microbubble destruction. To date,
nimal studies have focused on bioeffects in normal hearts.
t also seems likely that each organ could have a distinct
pectrum of potential bioeffects, which could be related
o blood flow, and structural characteristics that determine
he response to increased vascular permeability or cellular
amage.
It seems to us that the bioeffects of microbubble destruc-
ion resemble in many respects the side effects of pharma-
eutical agents. Medical school pharmacology emphasizes
he therapeutic window that exists for almost every useful
rug. However, this is not merely a simple matter of
nowing the upper and lower limits of dosing. Other
ariables that produce idiosyncratic variation in pharmaco-
ynamics will influence both efficacy and vulnerability to
ide effects. Similarly, it is likely that the bioeffects of
ltrasound-mediated microbubble destruction will prove to
e complex and variable. Nevertheless, the potential risk(s)
f this increasingly valuable clinical tool are an important
nd timely topic. The authors are to be congratulated for
eminding us, with these initial observations, of the need for
aution with any new technique. Clearly, much remains to
e learned.
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